StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Guardant Health (GH) PT Raised to $160 at BTIG, Second Day in a Row
May 27, 2026 12:49 PM
BTIG analyst Mark Massaro raised the price target on Guardant Health (NASDAQ: GH) to $160.00 (from $155.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
American Cancer Society Recommends Guardant Health’s Shield Blood Test in Updated Colorectal Cancer Screening Guidelines
May 27, 2026 7:48 AM
Form 4 Guardant Health, Inc. For: May 22 Filed by: Freeman Chris
May 26, 2026 5:38 PM
Guardant Health (GH) PT Raised to $155 at BTIG
May 26, 2026 6:11 AM